Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran

Indian Journal of Medical Research

Volumn 124, Issue 1, 2006, Pages 77-80

  Namaei, Mohammad H ^a   Sadeghian, Ali ^b   Naderinasab, Mahboobeh ^b   Ziaee, Masood ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ethambutol; Isoniazid; Multidrug resistance; Mycobacterium tuberculosis; Rifampicin; Streptomycin

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN TISSUE; IRAN; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; SMEAR;

ADULT; AGED; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE;

EID: 33748111331     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sethi S, Sharma S, Sharma SK, Meharwal SK, Jindal SK, Sharma M. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res 2004; 120 : 468-71.
2. Jain NK, Chopra KK, Prasad G. Initial and acquired INH and rifampicin resistant to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992; 39 : 180-6.
3. Nagpaul DR. Multidrug resistance in tuberculosis. Indian J Tuberc 1994; 41 : 1-2.
4. Bloom BR, Murray CJL. Tuberculosis: Commentary on a reemergent killer. Science 1992; 257 : 1055-64.
5. Bridging the gaps: the world health report. Geneva: World Health Organization; 1995.
6. Velayati AA, Masjedi MR, Mohammadi M. Textbook of tuberculosis. (Persian) Tehran: Markaz Nashr Daneshgahi; 1977.
7. Rieder HL, Chonde TM, Myking H, Urbanczik R, Laszlo A, Kim SJ, et al. The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network; Minimum Requirements, Role and Operation in a Low-Income Country. Paris: International Union Against Tuberculosis and Lung Disease (IUATLD); 1998.
8. Grange JM, Yates M, de Kantor IN. Guidelines for speciation within the Mycobacterium tuberculosis complex. 2nd ed. Geneva: World Health Organization; 1996.
9. The World Health Organization/International Union Against Tuberculosis and Lung Diseases global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world - Report no.2, prevalence and trends. Geneva: World Health Organization; 2000.
10. Annual report of tuberculosis in Khorasan. Provincial Center of Public Health, Mashhad University of Medical Science and Health Services, Mashhad; 2002.
11. Chakraborty AK. Epidemiology of tuberculosis: current status in India. Indian J Med Res 2004; 120 : 248-76.